2 ms·
It's important to have a control group to prevent the placebo effect in both the patients and in clinicians. If a patient thinks they are on a treatment, they
by londons_explore 4y ago
It's important to have a control group to prevent the placebo effect in both the patients and in clinicians.
If a patient thinks they are on a treatment, they might actually end up healthier than a patient who has just been told there are no treatment options left for them...
Likewise, if a clinician is really hoping the new drug they are developing is successful, their judgement of exactly how quickly a tumour is growing might not be fully impartial.
However, there is no need for the control group and treatment group to be 50/50. The control group can also be shared with other studies - although that makes risk budget allocation complex, but not impossible.
- BrandoElFollito 4y ago> If a patient thinks they are on a treatment, they might actually end up healthier than a patient who has just been told there are no treatment options left for them... Isn't the actual aim? to have someone heal? > Likewise, if a clinician is really hoping the new drug they are developing is successful, their judgement of exactly how quickly a tumour is growing might not be fully impartial Well, this is something that is quantifiable I guess (a measurement). And changes must be notable in order to call something a success in that case.
- carlineng 4y agoClinical trials for cancer treatment rarely use placebos. Instead, the control group is the current standard of care: https://www.cancer.net/research-and-advocacy/clinical-trials/placebos-cancer-clinical-trials https://www.cancer.net/research-and-advocacy/clinical-trials...